You are here

  • Home
  • Archive
  • Volume 72, Issue 12
  • A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hummers LK, Dugowson CE, Dechow FJ, et al
A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon
Annals of the Rheumatic Diseases 2013;72:1962-1967.